Sperm-associated antigen 9 is a biomarker for early cervical carcinoma

Cancer

Volumn 115, Issue 12, 2009, Pages 2671-2683

  Garg, Manoj ^a   Kanojia, Deepika ^a   Salhan, Sudha ^b   Suri, Sushma ^b   Gupta, Anju ^c   Lohiya, Nirmal Kumar ^d   Suri, Anil ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b SAFDARJUNG HOSPITAL   (India)

^c Moolchand Hospital   (India)

^d UNIVERSITY OF RAJASTHAN   (India)

Author keywords

Cancer testis antigen; Cervical carcinoma; Detection; Diagnosis; Sperm associated antigen 9 (SPAG9)

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; CYCLINE; MESSENGER RNA; SPERM ASSOCIATED ANTIGEN 9; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; UTERINE CERVIX CARCINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIBODY FORMATION; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 67649235656     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24293     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Syrjanen K, Kataja V, Yliskoski M, Chang F, Syrjanen S, Saarikoski S. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol. 1992;79:675-682.
3. Waggoner SE. Cervical cancer. Lancet. 2003;361:2217-2225. (Pubitemid 36782559)
4. Hsu KF, Huang SC, Shiau AL, et al. Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer. Int J Gynecol Cancer. 2007;17:174-181. (Pubitemid 46213988)
5. Gadducci A, Tana R, Fanucchi A, Genazzani AR. Biochemical prognostic factors and risk of relapses in patients with cervical cancer. Gynecol Oncol. 2007;107:S23-S26. (Pubitemid 47483872)
6. Suri A. Cancer testis antigens-their importance in immunotherapy and in the early detection of cancer. Expert Opin Biol Ther. 2006;6:379-389.
7. Napoletano C, Bellati F, Tarquini E, et al. MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy. Am J Obstet Gynecol. 2008;198:99.e1-99.e7. (Pubitemid 350309245)
8. Chang HK, Park JW, Kim WG, et al. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers. Gynecol Oncol. 2005;97:342-347. (Pubitemid 40626729)
9. Park S, Lim Y, Lee D, et al. Identification and characterization of a novel cancer/testis antigen gene CAGE-1. Biochim Biophys Acta. 2003;1625:173-182. (Pubitemid 36084487)
10. Hayashi E, Matsuzaki Y, Hasegawa G, et al. Identification of a novel cancer-testis antigen CRT2 frequently expressed in various cancers using representational differential analysis. Clin Cancer Res. 2007;13:6267-6274. (Pubitemid 350075014)
11. Hasegawa K, Koizumi F, Noguchi Y, et al. SSX expression in gynecological cancers and antibody response in patients. Cancer Immun. 2004;4:1-4.
12. Tureci O, Mack U, Luxemburger U, et al. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. Cancer Lett. 2006;236:64-71.
13. Garg M, Chaurasiya D, Rana R, et al. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res. 2007;13:1421-1428. (Pubitemid 46450431)
14. Kitahara O, Katagiri T, Tsunoda T, et al. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia. 2002;4:295-303. (Pubitemid 34755839)
15. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991;254:1643-1647. (Pubitemid 21917508)
16. Jagadish N, Rana R, Selvi R, et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem J. 2005;389:73-82. (Pubitemid 40978009)
17. Shankar S, Mohapatra B, Suri A. Cloning of a novel human testis mRNA specifically expressed in testicular haploid germ cells, having unique palindromic sequences and encoding a leucine zipper dimerization motif. Biochem Biophys Res Commun. 1998;243:561-565. (Pubitemid 28414064)
18. Kobayashi T, Masumoto J, Tada T, Nomiyama T, Hongo K, Nakayama J. Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas. Clin Cancer Res. 2007;13:3868-3874. (Pubitemid 47037593)
19. Jagadish N, Rana R, Mishra D, Garg M, Selvi R, Suri A. Characterization of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9). Vaccine. 2006;24:3695-3703.
20. Wang JL, Zheng BY, Li XD, Angstrom T, Lindstrom MS, Wallin KL. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res. 2004;10:2407-2414. (Pubitemid 38445700)
21. Davelaar EM, van de Lande J, von Mensdorff-Pouilly S, Blankenstein MA, Verheijen RHM, Kenemans P. Combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer. Tumor Biol. 2008;29:9-17. (Pubitemid 351733215)
22. Gadducci A, Tana R, Cosio S, Genazzani AR. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature. Crit Rev Oncol Hematol. 2008;66:10-20. (Pubitemid 351324130)
23. Holm R, Van de Putte G, Suo Z, Lie AK, Kristensen GB. Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis. Int J Med Sci. 2008;5:121-126. (Pubitemid 351880763)
24. Zhai Y, Hotary KB, Nan B, et al. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res. 2005;65:6543-6550. (Pubitemid 41060689)
25. Canevari S, Pupa SM, Menard S. 1975-1995 revised anticancer serological response: biological significance and clinical implications. Ann Oncol. 1996;7:227-232.
26. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5:615-625. (Pubitemid 41081387)
27. Garg M, Kanojia D, Khosla A, et al. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. Cancer Res. 2008;68:8240-8248.
28. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP. Scaffold proteins of MAP-kinase modules. Oncogene. 2007;26:3185-3202. (Pubitemid 46763014)